Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glutamate receptor ionotropic kainate subunits are integral membrane proteins that form part of the kainate class of ionotropic glutamate receptors (iGluRs). These receptors mediate fast excitatory neurotransmission in the central nervous system by functioning as ligand-gated cation channels activated primarily by the neurotransmitter glutamate. They play roles at both pre- and postsynaptic sites modulating synaptic transmission and influencing synaptic plasticity. Alterations or mutations in genes encoding these subunits have been linked to various neurological disorders including epilepsy, schizophrenia, intellectual disability, autism spectrum disorders.
Agonist binding leading to cation channel opening
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate Receptor Ionotropic Kainate Subunit (KAR subunit).